 Source: rafapress Shutterstock.com Clovis Oncology NASDAQ: CLVS stock is getting a boost on Wednesday as investors react to news of it reaching a two-year clinical supply agreement. That agreement was signed with Isotopia Molecular Imaging and it supplies Clovis Oncology with lutetium-177. 